Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

St. Louis stories

Nov 10, 2026

AstraZeneca acquires vaccine biotech Omniose to bolster pipeline

AstraZeneca acquired early-stage US biotech Omniose, which is developing vaccines against serious bacterial infections, integrating it into its infectious diseases division.

Nov 10, 2026·2 sources
00
Sep 25, 2026

Washington University finds Alzheimer's immune cells may originate in lymph nodes outside brain

Researchers at Washington University School of Medicine discovered that immune cells contributing to Alzheimer's-related brain damage may be activated in lymph nodes outside the brain before traveling into the nervous system. Blocking this pathway in mice dramatically reduced neurodegeneration and preserved cognitive abilities.

Sep 25, 2026·3 sources
00
Sep 6, 2026

Over 70% of Americans oppose data centers in their communities as Trump pushes expansion

New polling shows more than 70% of Americans across the political spectrum oppose data centers in their areas, even as President Donald Trump promotes them as beneficial to communities. The backlash comes as tech companies invest trillions in data centers to support AI infrastructure, with cities like St. Louis becoming battlegrounds in the national debate.

Sep 6, 2026·3 sources
00
Aug 9, 2026

Three St. Louis Men Charged in Bitcoin Kidnapping Plot Targeting Connecticut Home

Federal prosecutors have charged three men from St. Louis with planning to forcibly enter a Connecticut residence and compel the transfer of bitcoin connected to a theft valued at hundreds of millions of dollars. Each defendant faces up to 20 years in prison.

Aug 9, 2026·1 source
00

Top claims

  • ▪Bioconjugation streamlines conjugate vaccine manufacturing compared to traditional chemical attachment methods, offering a simpler approach designed to produce higher-quality vaccines targeting bacterial infections
  • ▪The acquisition of Omniose by AstraZeneca followed a three-year exclusive research collaboration between the two companies, with financial terms of the deal undisclosed
  • ▪Omniose's bioconjugation platform enables single E. coli cells to produce and link bacterial polysaccharide antigens to engineered carrier proteins in a single process

Topics

Mergers & acquisitions (M&A)Antimicrobial resistanceMergers and acquisitionsInfectious diseaseBiotech innovationVaccine developmentPharmaceutical IndustryBiotechnologyCorporate strategyBrain health & dementia researchersAlzheimer’s & dementiaCompute, chips & AI infrastructureU.S. domestic politicsAI compute & environmental impactCryptoBitcoin security & risksBitcoin

Related entities

United StatesEscherichia coli